Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Biodexa药品公司获得美国专利号12,011,445，标题为“预防胰岛细胞退化（治疗1型糖尿病）”。该专利是由Melior药品公司授权使用的。